TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
about
IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stabilityRegulation of the interleukin-1-induced signaling pathways by a novel member of the protein phosphatase 2C family (PP2Cepsilon)Inhibition of autophagy by TAB2 and TAB3The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathwaySTAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylationRBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradationThe MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokinesImplications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cellsTumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathwayInterleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosolProtein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathwayHSP90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathwayADIP, a novel Afadin- and alpha-actinin-binding protein localized at cell-cell adherens junctionsTAK1-dependent signaling requires functional interaction with TAB2/TAB3Reciprocal cross-talk between Nod2 and TAK1 signaling pathwaysPellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complexDirect binding of Lgl2 to LGN during mitosis and its requirement for normal cell divisionTAB3, a new binding partner of the protein kinase TAK1Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cellsReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activationInterleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathwayMKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokinesIdentification of a human NF-kappaB-activating protein, TAB3Role of the TAB2-related protein TAB3 in IL-1 and TNF signalingIL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activationMicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cellsPKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NF kappaB activationOsmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-kappaB activation: TAO2 regulates TAK1 pathwaysParallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgammaXIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 DimerizationMolecular Basis for the Unique Deubiquitinating Activity of the NF-κB Inhibitor A20The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory responseCellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.MAPPIT analysis of TLR adaptor complexesAutoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular processMutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal DysplasiaASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction
P2860
Q24291311-4562769A-DED3-44A7-83B7-46E8D8F392FCQ24293513-AF823498-A32A-4E07-B7E3-6DCE8B484539Q24297091-FFC4ED00-1985-4964-94A7-A158B07FBEA9Q24297208-2CE46065-3665-420F-87FA-6C3195505AB3Q24297971-3F33057A-B0B6-43EE-883B-8CF54D53D859Q24303616-5E6AA1A1-249B-4862-A4E2-B3D860086C62Q24304462-29808C53-8028-441F-9041-1707C0BC05DFQ24306339-E0897591-26B8-4BF8-89BD-67449B6A1D07Q24306909-5B0A8AF6-3033-42E9-BB17-2DB653D340DFQ24307324-5A759973-CBD3-4DC1-B791-717165B051FFQ24310895-BDE62F16-4E4F-4684-ABE7-09140559B68DQ24316474-6ABB275D-0E56-4299-B32D-DFFB12ED662EQ24320219-8890D95E-4302-4874-8F66-6EE608CEADCAQ24324222-5F0EE10E-233C-43E6-9CEF-F1D9224C2CF5Q24336336-FF869DD4-0309-4AEE-A0A1-2A67FF1F2963Q24337456-C12EEC6C-E61E-4E54-AE83-9C1D81388461Q24337491-59E6E726-F43D-4FC1-9F5D-7A26200D0664Q24530663-2069CA49-6937-4A3B-BC02-73D9B62A0B90Q24534892-87E3BC07-B0EE-46FB-B9B5-59314FD9B58EQ24537518-EFEEBF08-9120-4DE5-8562-08BFDF914DD6Q24548297-1AB2CE5C-0DE1-4494-8CAD-B4F8E4C7D046Q24550984-C6701B2E-8B76-4F64-BCF9-A914F451C16DQ24601753-20210893-0992-4A7D-BC7B-76D4575A1E1CQ24621651-39945AA7-9090-405E-8319-8FDEF170296AQ24633992-4C1B6C14-2525-47A4-B012-A9703EBF9D65Q24635274-CC6D85E6-51DD-4E1C-B00E-38E11D5FC4E9Q24641992-99A4F3AC-A7A2-419F-8915-333BEA65E39FQ24645977-150906F7-4A77-413A-BF4A-19BD9C89B33BQ24646391-4B40FF39-0A0F-49A5-9B37-8EFA746996E0Q24653915-086A29A5-24B7-4A06-9D98-857F17FC468BQ24676236-246C605A-D4F3-4E51-B6D5-CF6C068E9304Q24685818-C919BBC2-3A5E-4E9F-B1C9-7D53409289F6Q27645534-47E05513-1F9A-417D-BEC4-D6016F5D315BQ27649460-C5B96D5C-ED1F-41DE-A6EC-3EDD8D2F6B4EQ27677993-ABE3451E-18CE-4291-B536-E3B7A45EF1BBQ27692108-21BB5915-F761-48EA-9F1C-E27A7ACCCC3DQ28116168-B76E0A32-8326-4FA9-9F10-C4E42A3BF0F1Q28117206-F2CDE8EC-3FE5-49F5-8724-E60F40D68AF6Q28117317-86A0BFFB-2E53-4A63-88B8-B7708DB44DCBQ28142377-4999E1CF-D933-4317-A60C-EAB259F014DC
P2860
TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@ast
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@en
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@nl
type
label
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@ast
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@en
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@nl
prefLabel
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@ast
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@en
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@nl
P2093
P3181
P1433
P1476
TAB2, a novel adaptor protein, ...... -1 signal transduction pathway
@en
P2093
J Ninomiya-Tsuji
K Matsumoto
K Yamaguchi
P304
P3181
P356
10.1016/S1097-2765(00)80244-0
P407
P577
2000-04-01T00:00:00Z